What Will the Trump-Era Crackdown on Drug Ads Accomplish?

What Will the Trump-Era Crackdown on Drug Ads Accomplish?

The federal government has announced a new approach to regulating pharmaceutical ads, which may not be noticeable to consumers.

The Department of Health and Human Services, overseen by Secretary Robert F. Kennedy Jr., has taken a stance on direct-to-consumer advertising by pharmaceutical companies. In a post, the agency stated that drug ads

“can push people to take drugs they don’t actually need. Americans often end up harmed instead of helped.”

President Donald Trump and Kennedy

“are taking action”
to address this issue, with the most immediate evidence being a presidential memorandum on
“misleading”
direct-to-consumer prescription drug ads.

Author's summary: Trump-era crackdown on drug ads aims to reduce harm.

more

Undark Magazine Undark Magazine — 2025-10-27

More News